MgShell to participate at 2024 Italian Tech Week in Turin, 25-27 September 2024
Milan, Italy (September 21, 2024) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its attendance at 2024 Italian Tech Week. Marco Ferroni, Chief Executive Officer, will be […]
MgShell to participate at 2024 Bolzano Slush’D in Bolzano, 3 September 2024
Milan, Italy (August 27, 2024) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its attendance at 2024 Bolzano Slush’D. Marco Ferroni, Chief Executive Officer, will be attending […]
MgShell named Startup of the Year of the SESA and finalist of Global Startup Awards
Milan, Italy (August 27, 2024) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its victory in the Startup of the Year category of the South Europe Startup […]
MgShell and Marco Ferroni finalists of SESA Awards
Milan, Italy (June 20, 2024) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its nomination as finalist in the Startup of the Year 2023 category of the […]
MgShell was nominated to pitch at the European event Stage Two on October 19, 2023 in Berlin
Milan, Italy (September 20, 2023) Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its attendance at the 2023 edition of Stage Two. MgShell is proud to announce […]
